发明名称 |
COMPOUNDS FOR THE TREATMENT OF RENAL CELL CARCINOMA |
摘要 |
A composition comprising mithramycin or a pharmaceutically acceptable salt or solvate thereof for use in the treatment of renal cell carcinoma. In particular, the composition is suitable for use in the treatment of clear cell renal cell carcinoma. The composition is particularly useful for use in the treatment of renal cell carcinoma associated with Von Hippel-Lindau disease or Birt-Hogg-Dubé syndrome. A composition comprising mithramycin or a pharmaceutically acceptable salt or solvate thereof for use as a cytotoxic agent against FLCN-null or VHL-null renal cell carcinoma cells.
|
申请公布号 |
US2013150317(A1) |
申请公布日期 |
2013.06.13 |
申请号 |
US201113579420 |
申请日期 |
2011.02.17 |
申请人 |
MAHER EAMONN;LU XIAOHONG;MYROVLYTIS TECHNOLOGY VENTURES LIMITED |
发明人 |
MAHER EAMONN;LU XIAOHONG |
分类号 |
A61K31/704;A61K31/436;C07H15/24 |
主分类号 |
A61K31/704 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|